Literature DB >> 6491527

Hepatic triacylglycerol synthesizing activity during progression of alcoholic liver injury in the baboon.

M J Savolainen, E Baraona, P Pikkarainen, C S Lieber.   

Abstract

To study the effects of alcoholic liver injury on the ability of ethanol to promote hepatic fat accumulation and hyperlipemia, baboons were pair-fed liquid diets containing 50% of energy either as ethanol or as additional carbohydrate (controls) for 1 to 7 years. Alcohol consumption produced triacylglycerol accumulation in the liver, hypertriacylglyceridemia, and various degrees of liver injury, including cirrhosis. At the early stages of fatty liver (with or without perivenular fibrosis), there was increased activity of microsomal diacylglycerol acyltransferase and of both microsomal and cytosolic phosphatidate phosphohydrolase, with no changes in glycerol-3-phosphate acyltransferase. With progression of the liver injury and development of septal fibrosis and/or cirrhosis, the rate of hepatic triacylglycerol accumulation and the magnitude of the hyperlipemia decreased, despite continuous ethanol intake. These changes were associated with disappearance of the increases in microsomal diacylglycerol acyltransferase and cytosolic phosphatidate phosphohydrolase activities, whereas those of microsomal phosphatidate phosphohydrolase remained elevated and glycerol-3-phosphate acyltransferase was unaffected. Thus, changes in the activity of two enzymes of the triacylglycerol-synthesizing pathway, namely the microsomal diacylglycerol acyltransferase and the cytosolic phosphatidate phosphohydrolase, may contribute to the differences in the rate of hepatic triacylglycerol accumulation and the degree of hyperlipemia during progression of the alcoholic liver damage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491527

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice.

Authors:  Ming Hu; Fengming Wang; Xin Li; Christopher Q Rogers; Xiaomei Liang; Brian N Finck; Mayurranjan S Mitra; Ray Zhang; Dave A Mitchell; Min You
Journal:  Hepatology       Date:  2011-12-29       Impact factor: 17.425

Review 2.  Signal Transduction Mechanisms of Alcoholic Fatty Liver Disease: Emer ging Role of Lipin-1.

Authors:  Min You; Alvin Jogasuria; Kwangwon Lee; Jiashin Wu; Yanqiao Zhang; Yoon Kwang Lee; Prabodh Sadana
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

Review 3.  Sirtuin 1 signaling and alcoholic fatty liver disease.

Authors:  Min You; Alvin Jogasuria; Charles Taylor; Jiashin Wu
Journal:  Hepatobiliary Surg Nutr       Date:  2015-04       Impact factor: 7.293

Review 4.  Effect of ethanol on lipid metabolism.

Authors:  Min You; Gavin E Arteel
Journal:  J Hepatol       Date:  2019-02       Impact factor: 25.083

5.  Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice.

Authors:  Zheng Shen; Xiaomei Liang; Christopher Q Rogers; Drew Rideout; Min You
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-10       Impact factor: 4.052

6.  Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver.

Authors:  Huquan Yin; Ming Hu; Xiaomei Liang; Joanne M Ajmo; Xiaoling Li; Ramon Bataller; Gemma Odena; Stanley M Stevens; Min You
Journal:  Gastroenterology       Date:  2013-11-18       Impact factor: 22.682

7.  Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically.

Authors:  Boripont Manmontri; Meltem Sariahmetoglu; Jimmy Donkor; Maroun Bou Khalil; Meenakshi Sundaram; Zemin Yao; Karen Reue; Richard Lehner; David N Brindley
Journal:  J Lipid Res       Date:  2008-02-02       Impact factor: 5.922

8.  Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice.

Authors:  Ming Hu; Huquan Yin; Mayurranjan S Mitra; Xiaomei Liang; Joanne M Ajmo; Karim Nadra; Roman Chrast; Brian N Finck; Min You
Journal:  Hepatology       Date:  2013-10-17       Impact factor: 17.425

9.  Circulating Lipids Are Associated with Alcoholic Liver Cirrhosis and Represent Potential Biomarkers for Risk Assessment.

Authors:  Peter J Meikle; Piyushkumar A Mundra; Gerard Wong; Khairunnessa Rahman; Kevin Huynh; Christopher K Barlow; Alastair M P Duly; Paul S Haber; John B Whitfield; Devanshi Seth
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.